First Tracks Biotherapeutics, Inc.
TRAX
$44.04
$0.010.02%
NASDAQ
| 06/30/2026 | 03/31/2026 | 06/30/2025 | |||
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | ||
| Total Other Revenue | -- | -- | -- | ||
| Total Revenue | -- | -- | -- | ||
| Cost of Revenue | -- | -- | -- | ||
| Gross Profit | -- | -- | -- | ||
| SG&A Expenses | 9.29M | 18.86M | 6.63M | ||
| Depreciation & Amortization | -- | -- | -- | ||
| Other Operating Expenses | -- | -- | -- | ||
| Total Operating Expenses | 34.94M | 52.81M | 45.90M | ||
| Operating Income | -34.94M | -52.81M | -45.90M | ||
| Income Before Tax | -33.37M | -50.48M | -42.45M | ||
| Income Tax Expenses | -- | -- | -- | ||
| Earnings from Continuing Operations | -33.37M | -50.48M | -42.45M | ||
| Earnings from Discontinued Operations | -- | -- | -- | ||
| Extraordinary Item & Accounting Change | -- | -- | -- | ||
| Minority Interest in Earnings | -- | -- | -- | ||
| Net Income | -33.37M | -50.48M | -42.45M | ||
| EBIT | -34.94M | -52.81M | -45.90M | ||
| EBITDA | -34.83M | -52.69M | -45.76M | ||
| EPS Basic | -0.95 | -1.45 | -1.47 | ||
| Normalized Basic EPS | -0.60 | -0.90 | -0.92 | ||
| EPS Diluted | -0.95 | -1.45 | -1.47 | ||
| Normalized Diluted EPS | -0.60 | -0.90 | -0.92 | ||
| Average Basic Shares Outstanding | 35.00M | 34.89M | 28.81M | ||
| Average Diluted Shares Outstanding | 35.00M | 34.89M | 28.81M | ||
| Dividend Per Share | -- | -- | -- | ||
| Payout Ratio | -- | -- | -- | ||